Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients
Based on antitumor activity of statin, we designed a phase III study of capecitabine/CDDP chemotherapy plus a low-dose simvastatin that is equivalent to cardiovascular dose in advanced gastric cancer patients.
Gastric Cancer
DRUG: Simvastatin|DRUG: Placebo
Progression free survival of XP Â± simvastatin, 1-year PFS
Based on antitumor activity of statin, we designed a phase III study of capecitabine/CDDP chemotherapy plus a low-dose simvastatin that is equivalent to cardiovascular dose in advanced gastric cancer patients.